Rituximab in CD20 positive multiple myeloma

被引：0
|
作者：
J M Bergua
C Cabrera
E G Arteta
J Prieto
机构：
[1] Servicio de Hematología,
[2] Hospital San Pedro de Alcántara,undefined
[3] Avda. Pablo Naranjo s/n,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1082 / 1083
页数：1
相关论文
共 50 条
  • [41] Unexpected toxicities of combined rituximab and GM-CSF in autologous transplants for CD20 positive lymphoma.
    Ehmann, WC
    Mierski, JA
    Claxton, DF
    Rybka, WB
    BLOOD, 2001, 98 (11) : 345B - 346B
  • [42] Loss of CD20 expression on CLL cells following treatment with rituximab
    Poirot, Brigitte
    Chedani, Hicham
    Abbed, Karim
    Tertian, Gerard
    Raphael, Martine
    Besson, Caroline
    HEMATOLOGIE, 2010, 16 (01): : 92 - 95
  • [43] Loss of CD20 expression in relapsed lymphomas after rituximab therapy
    Haidar, JH
    Shamseddine, A
    Salem, Z
    Mrad, YA
    Nasr, MR
    Zaatari, G
    Bazarbachi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (05) : 330 - 332
  • [44] CD20
    Warzynski, MJ
    Graham, DM
    Axtell, RA
    Zakem, MH
    Rotman, RK
    APPLIED IMMUNOHISTOCHEMISTRY, 1996, 4 (03): : 218 - 218
  • [45] CD20
    Macardle, PJ
    Nicholson, IC
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2002, 16 (02): : 136 - 138
  • [46] MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB
    Rice, Ceara
    Ghandi-Das, Dhivya
    Negi, Anurag
    RHEUMATOLOGY, 2020, 59 : 94 - 94
  • [47] Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases
    Reis, J.
    Aguiar, F.
    Brito, I
    ACTA REUMATOLOGICA PORTUGUESA, 2016, 41 (01): : 45 - 55
  • [48] A novel CD20/CD3 T cell engager designed from Rituximab targeting CD20+cancer with multiple mechanisms.
    Cai, Wenyan
    Dong, Jianbo
    Kankanamalage, Sachith Gallolu
    Titong, Allison
    Shi, Jiadong
    Jia, Zhejun
    Wang, Bo
    Huang, Cai
    Zhang, Jing
    Lin, Jun
    Kan, Steven Z.
    Zhou, Joe
    Liu, Yuc
    CANCER RESEARCH, 2021, 81 (13)
  • [49] Pulmonary parenchymal infiltrates in a patient with CD20-positive multiple myeloma
    Yokote, T
    Akioka, T
    Miyamoto, H
    Oka, S
    Hara, S
    Yamano, T
    Takasu, T
    Tsuji, M
    Hanafusa, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (01) : 61 - 65
  • [50] CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma
    Robillard, N
    Avet-Loiseau, H
    Garand, R
    Moreau, P
    Pineau, D
    Rapp, MJ
    Harousseau, JL
    Bataille, R
    BLOOD, 2003, 102 (03) : 1070 - 1071
12345